228 related articles for article (PubMed ID: 25240629)
1. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease.
Aragona P; Aguennouz M; Rania L; Postorino E; Sommario MS; Roszkowska AM; De Pasquale MG; Pisani A; Puzzolo D
Ophthalmology; 2015 Jan; 122(1):62-71. PubMed ID: 25240629
[TBL] [Abstract][Full Text] [Related]
2. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
3. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls.
Menzies KL; Srinivasan S; Prokopich CL; Jones L
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):836-41. PubMed ID: 25574045
[TBL] [Abstract][Full Text] [Related]
4. Acidic mammalian chitinase in dry eye conditions.
Musumeci M; Aragona P; Bellin M; Maugeri F; Rania L; Bucolo C; Musumeci S
Cornea; 2009 Jul; 28(6):667-72. PubMed ID: 19512904
[TBL] [Abstract][Full Text] [Related]
5. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye.
Sambursky R; Davitt WF; Latkany R; Tauber S; Starr C; Friedberg M; Dirks MS; McDonald M
JAMA Ophthalmol; 2013 Jan; 131(1):24-8. PubMed ID: 23307206
[TBL] [Abstract][Full Text] [Related]
7. In vivo confocal microscopy of meibomian glands in Sjögren's syndrome.
Villani E; Beretta S; De Capitani M; Galimberti D; Viola F; Ratiglia R
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):933-9. PubMed ID: 21169534
[TBL] [Abstract][Full Text] [Related]
8. Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease.
Zhang L; Su Z; Zhang Z; Lin J; Li DQ; Pflugfelder SC
JAMA Ophthalmol; 2015 Oct; 133(10):1117-23. PubMed ID: 26204109
[TBL] [Abstract][Full Text] [Related]
9. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial.
Lee H; Chung B; Kim KS; Seo KY; Choi BJ; Kim TI
Am J Ophthalmol; 2014 Dec; 158(6):1172-1183.e1. PubMed ID: 25128594
[TBL] [Abstract][Full Text] [Related]
11. Meibomian gland dysfunction in patients with Sjögren syndrome.
Shimazaki J; Goto E; Ono M; Shimmura S; Tsubota K
Ophthalmology; 1998 Aug; 105(8):1485-8. PubMed ID: 9709762
[TBL] [Abstract][Full Text] [Related]
12. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
13. Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome.
Sullivan DA; Dana R; Sullivan RM; Krenzer KL; Sahin A; Arica B; Liu Y; Kam WR; Papas AS; Cermak JM
Ophthalmic Res; 2018; 59(4):193-205. PubMed ID: 29627826
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
15. Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.
Lim SA; Nam DH; Lee JH; Kwok SK; Park SH; Chung SH
Cornea; 2015 Mar; 34(3):248-52. PubMed ID: 25603233
[TBL] [Abstract][Full Text] [Related]
16. Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease.
Albietz JM; Lenton LM
Cornea; 2006 Oct; 25(9):1012-9. PubMed ID: 17133045
[TBL] [Abstract][Full Text] [Related]
17. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the clinical course of dry eye syndrome.
Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
[TBL] [Abstract][Full Text] [Related]
19. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Afonso AA; Monroy D; Stern ME; Feuer WJ; Tseng SC; Pflugfelder SC
Ophthalmology; 1999 Apr; 106(4):803-10. PubMed ID: 10201606
[TBL] [Abstract][Full Text] [Related]
20. Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers.
Ko JS; Seo Y; Chae MK; Jang SY; Yoon JS
Eye (Lond); 2018 Feb; 32(2):439-445. PubMed ID: 29052604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
